MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells

Triple-negative breast cancer shows worse outcome compared with other subtypes of breast cancer. The discovery of dysregulated microRNAs and their roles in the progression of triple-negative breast cancer provide novel strategies for the treatment of patients with triple-negative breast cancer. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guochen, Wang, Junlan, Zheng, Ruilin, Song, Beibei, Huang, Li, Liu, Yujiang, Hao, Yating, Bai, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278099/
https://www.ncbi.nlm.nih.gov/pubmed/32462982
http://dx.doi.org/10.1177/1533033820927011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278099/
https://www.ncbi.nlm.nih.gov/pubmed/32462982
http://dx.doi.org/10.1177/1533033820927011

Ejemplares similares